Inventors:
Bruce K. Rubin - Richmond VA, US
Soichiro Kanoh - Tokyo, JP
Tsuyoshi Tanabe - Richmond VA, US
International Classification:
A61K 31/145, A61P 29/00
Abstract:
Aerosolized dapsone (or alternatively, an aqueous formulation of dapsone) is used to treat airway inflammation, particularly chronic neutrophil-dominated inflammation. Diseases that may be prevented or treated by the methods include chronic obstructive pulmonary diseases (COPDs), asthma, cystic fibrosis, and others.